Skip to main content
. 2019 Jan 1;10(1):43–50. doi: 10.7150/jca.26723

Figure 3.

Figure 3

Exploration to identify circulating miR-1290 and miR-320d as novel biomarkers for early diagnosis of CRC. A-B. Plasma miR-1290 and miR-320d were significantly dysregulated in both adenoma and CRC patients. C-D. The diagnostic utility of plasma miR-1290 and miR-320d to distinguish adenoma and CRC patients from healthy controls. ***P<0.001.